Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2016; 141(19): 1404-1406
DOI: 10.1055/s-0042-110616
DOI: 10.1055/s-0042-110616
Standpunkt
Polio-Impfung
Eine StandortbestimmungPolio vaccination – where we stand nowFurther Information
Publication History
Publication Date:
29 August 2016 (online)
![](https://www.thieme-connect.de/media/dmw/201619/lookinside/thumbnails/10-1055-s-0042-110616-1.jpg)
Das Ziel, die Polio auszurotten, rückt immer weiter in die Ferne. Das liegt nicht zuletzt auch am empfohlenen Totimpfstoff. Denn dieser verursacht keine Darmimmunität – und so können geimpfte Personen in Endemiegebieten jahrelang unbemerkt Polioviren ausscheiden. Durch die Flüchtlingskrise wächst die Gefahr, dass die Viren auf diese Weise auch in poliofreie Gebiete eingeschleppt werden.
-
Literatur
- 1 Sutter RW, Suleiman AJM, Malankar P et al. Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med 2000; 343: 767-773
- 2 Modin JF. The bumb road to polio eradication. N Engl J Med 2010; 362: 2346-2349
- 3 Evans AS. Criteria for assessing accomplishment of poliomyelitis control. Rev Infect Dis 1984; 6: S571-576
- 4 Arya SC. Hiding polioviruses. Lancet 2003; 361: 2156-2157
- 5 Macadam AJ, Arnold C, Howlett J et al. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccines. Virology 1989; 172: 408-414
- 6 Minor PD. Attenuation and reversion of the Sabon vaccine strains of poliovirus. Dev Biol Standard 1993; 78: 17-26
- 7 Friedrich F. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy vontacts and healthy vaccinees. Acta Virol 1996; 40: 157-170
- 8 Melnick JL. Poliomyelitis vaccination – what are the options. Clin Immunother 1996; 6: 1-6
- 9 Beale AJ. Efficacy and safety of oral poliovirus vaccine and inactivated poliovirus vaccine. Pediatr Infect Dis J 1991; 10: 970-972
- 10 Dove AW, Racaniello VR. The polio eradication effort: should vaccine eradication be next?. Science 1997; 277: 779-780
- 11 Kew OM, Wright PF, Agol VI et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull WHO 2004; 82: 16-23
- 12 Anonymus: La région Europe de l’OMS indemne de poliomyélite / The WHO european region declard free of polio. Eurosurveillance 2002; 7: 76-77
- 13 Cochi SL, Linkins RW. The finale phase of polio eradication: new vacines and complex choices. J. Infect Dis 2012; 205: 169-171
- 14 [Anonym]. Update on vaccine-derived poliovirusus – worldwide, July 2012 -December 2013. MMWR 2014; 63: 242-248
- 15 [Anonym]. Global polio eradication initiative. Polio this week as of 23 March 2016. http://www.polioeradication.org/Dataandmonitoring/poliothisweek.aspx Letzter Zugriff: 21.06.2016
- 16 Yang C-F, Naguib T, Yang S-J et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt. J Virol 2003; 77: 8366-8377
- 17 Shimizu H, Thorley B, Paladin FJ et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines. J Virol 2004; 78: 13512-13521
- 18 Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandressy R et al. Recombinant vaccine-derived polioviris in Madagascar. Emerg Infect Dis 2003; 9: 885-887
- 19 Rakoto-Andrianarivelo M, Gumede N Jegouic et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis 2008; 197: 1427-1437
- 20 Ling X, Zhang Y, Xu W et al. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J Infect Dis 2006; 194: 545-551
- 21 Gumede N, Lentsoane O, Burns CC et al. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004–2011. Emerg Infect Dis 2013; 19: 1583-1589
- 22 Jenkins HE, Aylward RB, Gasasira A et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 2010; 362: 2360-2369
- 23 Roberts L. The art of eradicating polio. Science 2013; 342: 29-35
- 24 Estivariz CF, Watkins MA, Handoko D et al. A large vaccine-derived poliovirus outbreak on Madura Island-Indonesia. 2005. J Infect Dis 2008; 197: 347-354
- 25 [Anonym]. Progress towards poliomyelitis eradication – Egypt, 2003–2004. MMWR 2004; 53: 820-822
- 26 Lösch R, Klare U. Poliomyelitis breitet sich in Ostafrika aus. Flug-, Tropen- Reisemed 2013; 20: 213
- 27 [Anonym]. Outbreak of polio in adults – Namibia, 2006. MMWR 2006; 55: 1198-1201
- 28 [Anonym]. Outbreaks following wild poliovirus importations – Europe, Africa, and Asia, January 2009 – September 2010. MMWR 2010; 59: 1393-1399
- 29 Luo H-M, Zhang Y, Wang X-Q et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med 2013; 369: 1981-1990
- 30 [Anonym]. Progress towards poliomyelitis eradication – Afghanistan, January 2012 – September 2013. MMWR 2013; 62: 928-933
- 31 Roberts L. Israels’s silent polio epidemic breaks all the rules. Science 2013; 342: 679-680
- 32 Tulchinsky TH, Ramlawi A, Abdeen Z et al. Polio lessons 2013: Israel, the West Bank, and Gaza. Lancet 2013; 382: 1611-1612
- 33 Herremans T, Kimman TG, Conyn-van Spaendonck MAE et al. Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population. Clin Infect Dis 2002; 34: 1067-1075
- 34 [Anonym]. Importation of wild poliovirus in environmental (sewage) samples in Egypt. http://http://www.emro.who.int/polio/polio-news/new-polio-virus-egypt.html Letzter Zugriff: 21.06.2016
- 35 Mohammadi D. Middle Easern countries scramble to stop spread of polio. Lancet 2013; 382: 1621-1622
- 36 Rutter PD, Donaldson LJ. Mandatory poliovaccination for travellers: protecting global public health. Lancet 2014; 383: 1695-1696
- 37 Eichner M, Brockmann SO. Polio emergence in Syria and Israel endangers Europe. Lancet 2013; 382: 1777
- 38 Celentano LP, Lopalco PL, Hitric E et al. Polio and the risk for the European Union. Lancet 2014; 383: 216-217
- 39 Mundel T, Orenstein WA. No country is safe without global erdadication of poliomyelitis. N Engl J Med 2013; 369: 2045-2046
- 40 Razum O, Müller O. Polio eradication: where are we now?. Lancet 2013; 382: 1979
- 41 Lycke E, Magnius LO, Norder H. Should we use oral polio vaccine in Europe?. Lancet 2014; 383: 1037-1038
- 42 Bancroft EA, Carillo-Santisvere P, Celentano LP et al. Author’s reply. Lancet 2014; 383: 1038
- 43 Riedl-Seifert R. Praxisferne Überlegungen setzen Erfolg aufs Spiel. Schluckimpfung passé – ein Fehler. Ärztl Praxis Nr 54 7.7.2000
- 44 Thompson KM, Tebbens RJD. Eradication versus control for poliomyelitis: an economic analysis. Lancet 2007; 369: 1363-1371
- 45 Babadoko S. Sharia body wants polio vaccination suspended – Says it contains anti-pregnancy agents. Daily Trust 28.07.2003
- 46 [Anonym]. Polio eradication: the CIA and their unintended victims. Lancet 2014; 383: 1862
- 47 Fish EN, Flanagan KL, Furman D et al. Changing oral vaccine to inactivated poliovaccine might increase mortality. Lancet 2016; 387: 1054-1055
- 48 Müller HE. Pockenimpfung – Plädoyer für eine Wiedereinführung. Dtsch Ärztebl 2004; 101: A2090-2091
- 49 Lund N, Andersen A, Hansen AS et al. The effect of oral polio vaccine at birth on infant mortality: a randomized trial. Clin Infect Dis 2015; 61: 1504-1511
- 50 Aaby P, Garly ML, Nielsen J et el. Increased female-male mortality ratio asssociated with inactivated polio and diphtheria-tetanus-pertussis vaccines: observations from vaccination trials in Guinea-Bissau. Pediatr Infect Dis J 2007; 26: 247-252